Contractor profile
Janssen Pharmaceuticals, Inc.
FY2021 · complete year · data as of 2026-07-12
No FY2026 activity recorded for this recipient. Showing FY2021, its most recent year with data.
prime recipient of federal awards · UEI RDJSZL3THV47 Source
$486.3M
Obligated
FY2021
1
Funding agencies
100%
From Health and Hum…
1
Industries
In FY2021, Janssen Pharmaceuticals, Inc. received $486.3M in federal awards from the Department of Health and Human Services. Across FY2020 to FY2021 its recorded total is $1.2B. Computed
Where this money comes from
SourceFUNDING AGENCIES
JANSSEN PHARMACEUTICALS,
HHS
$0.5B
Janssen Pharmaceuticals, Inc.
$0.5B
FY2021 obligated
Where the work lands
No places of performance recorded.
Key takeaways
Computed- Janssen Pharmaceuticals, Inc. received $486.3M in federal obligations in FY2021, down 33% from $724.7M in FY2020.
- The Department of Health and Human Services accounted for 100% of it.
- Its largest recorded industry was Research and Development in Biotechnology, at $486.3M.
Obligations by year
Computed$724.7M
FY20
$486.3M
FY21
▼ 33%
since FY20
Awards
SourceLargest active awards by total value
Awards whose period of performance overlaps FY2021, by the amount obligated on each so far.
No award on record was active in FY2021.
Largest FY2021 awards
Awards that started in FY2021, by the amount obligated on each so far.
No award on record started in FY2021.
What it does (NAICS / PSC)
Corporate family
Single registration: no combined family.
Related
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.